0001209191-14-060597.txt : 20141001 0001209191-14-060597.hdr.sgml : 20141001 20141001171844 ACCESSION NUMBER: 0001209191-14-060597 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140930 FILED AS OF DATE: 20141001 DATE AS OF CHANGE: 20141001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Horton Kenneth L CENTRAL INDEX KEY: 0001552047 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 141133912 MAIL ADDRESS: STREET 1: VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-09-30 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001552047 Horton Kenneth L C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP & Chief Legal Officer Common Stock 2014-09-30 4 M 0 36000 55.83 A 68463 D Common Stock 2014-09-30 4 S 0 4713 111.33 D 63750 D Common Stock 2014-09-30 4 S 0 14286 112.22 D 49464 D Common Stock 2014-09-30 4 S 0 9601 113.10 D 39863 D Common Stock 2014-09-30 4 S 0 7400 113.91 D 32463 D Common Stock 366 I 401(k) Stock Option (right to buy) 55.83 2014-09-30 4 M 0 36000 0.00 D 2022-06-10 Common Stock 36000 36000 D Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $111.33 (range $110.61 to $111.60). Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $112.22 (range $111.61 to $112.60). Open market sales reported on this line occurred at a weighted average price of $113.10 (range $112.61 to $113.60). Open market sales reported on this line occurred at a weighted average price of $113.91 (range $113.62 to $114.41). The option vests in 16 quarterly installments from 06/11/2012. Kenneth L. Horton 2014-10-01